Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Rating Increased to Sell at Wall Street Zen

Wall Street Zen upgraded shares of Greenland Mines Ltd. Common Stock (NASDAQ:GRML) to a sell rating in a research note published on Saturday.

Separately, Weiss Ratings upgraded shares of Greenland Mines Ltd. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Greenland Mines Ltd. Common Stock currently has a consensus rating of “Sell”.

Greenland Mines Ltd. Common Stock Stock Performance

Shares of Greenland Mines Ltd. Common Stock stock opened at $4.88 on Friday. The business’s 50 day simple moving average is $10.26 and its 200 day simple moving average is $17.38. Greenland Mines Ltd. Common Stock has a 52-week low of $4.37 and a 52-week high of $36.99. The firm has a market cap of $15.52 million, a PE ratio of -15.25 and a beta of 7.13.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) last released its quarterly earnings results on Monday, August 17th. The company reported ($0.03) earnings per share for the quarter.

Insider Buying and Selling at Greenland Mines Ltd. Common Stock

In related news, Director Jason David Sawyer purchased 4,800 shares of the stock in a transaction on Wednesday, July 22nd. The shares were purchased at an average price of $11.50 per share, with a total value of $55,200.00. Following the transaction, the director directly owned 4,800 shares of the company’s stock, valued at $55,200. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Riad Hussein El-Dada sold 3,500 shares of the stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.50, for a total value of $40,250.00. Following the completion of the sale, the director directly owned 3,500 shares of the company’s stock, valued at approximately $40,250. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 11.30% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Jane Street Group LLC acquired a new position in shares of Greenland Mines Ltd. Common Stock during the 2nd quarter worth about $26,000. Brummer Multi Strategy AB acquired a new position in Greenland Mines Ltd. Common Stock during the fourth quarter worth approximately $175,000. Geode Capital Management LLC raised its stake in Greenland Mines Ltd. Common Stock by 51.8% in the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after buying an additional 167,905 shares during the period. Renaissance Technologies LLC bought a new stake in Greenland Mines Ltd. Common Stock in the fourth quarter valued at approximately $126,000. Finally, XTX Topco Ltd raised its stake in Greenland Mines Ltd. Common Stock by 101.2% in the fourth quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock valued at $46,000 after buying an additional 80,768 shares during the period. Institutional investors own 20.07% of the company’s stock.

About Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.